Search research articles
Contact Us
Filters
Showing results (271-280 of 466) with videos related to
Page
of 47
Sort By:
The Journal of Pathology
|
March 4, 2025
The significance of PAX5 in Merkel cell carcinoma
Emil Chteinberg, Julia Kolarova, Julia Vogt, et al.
Blood
|
April 19, 2011
Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia
William G Wierda, Thomas J Kipps, Jan Dürig, et al.
Leukemia & Lymphoma
|
January 15, 2016
Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial
Clemens M Wendtner, Michael Hallek, Graeme A M Fraser, et al.
Haematologica
|
August 29, 2015
Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG)
Paula Cramer, Susanne Isfort, Jasmin Bahlo, et al.
American Journal of Hematology
|
June 22, 2019
Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL)
Othman Al-Sawaf, Alexandra Bazeos, Sandra Robrecht, et al.
Journal of Cancer Research and Clinical Oncology
|
January 17, 2025
Exploiting somatic oncogenic driver alterations in a patient with Li-Fraumeni syndrome- paving the path towards precision medicine: a case report
Carolin Seeling, Sonja Dahlum, Ralf Marienfeld, et al.
British Journal of Haematology
|
June 7, 2018
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials
Jeffrey Jones, Anthony Mato, Steven Coutre, et al.
Leukemia & Lymphoma
|
April 26, 2013
Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia
G Doreen te Raa, Jitka Malcikova, Sarka Pospisilova, et al.
Leukemia
|
February 2, 2021
EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4<sup>+</sup> T cells in chronic lymphocytic leukemia
Philipp M Roessner, Laura Llaó Cid, Ekaterina Lupar, et al.
Blood
|
April 12, 2012
Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial
Peter Dreger, Hartmut Döhner, Fabienne McClanahan, et al.
Page
of 47
Search research articles
Search
Showing results (271-280 of 466) with videos related to
Sort By:
Page
of 47
The Journal of Pathology
|
March 4, 2025
The significance of PAX5 in Merkel cell carcinoma
Emil Chteinberg, Julia Kolarova, Julia Vogt, et al.
Blood
|
April 19, 2011
Chemoimmunotherapy with O-FC in previously untreated patients with chronic lymphocytic leukemia
William G Wierda, Thomas J Kipps, Jan Dürig, et al.
Leukemia & Lymphoma
|
January 15, 2016
Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial
Clemens M Wendtner, Michael Hallek, Graeme A M Fraser, et al.
Haematologica
|
August 29, 2015
Outcome of advanced chronic lymphocytic leukemia following different first-line and relapse therapies: a meta-analysis of five prospective trials by the German CLL Study Group (GCLLSG)
Paula Cramer, Susanne Isfort, Jasmin Bahlo, et al.
American Journal of Hematology
|
June 22, 2019
Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL)
Othman Al-Sawaf, Alexandra Bazeos, Sandra Robrecht, et al.
Journal of Cancer Research and Clinical Oncology
|
January 17, 2025
Exploiting somatic oncogenic driver alterations in a patient with Li-Fraumeni syndrome- paving the path towards precision medicine: a case report
Carolin Seeling, Sonja Dahlum, Ralf Marienfeld, et al.
British Journal of Haematology
|
June 7, 2018
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials
Jeffrey Jones, Anthony Mato, Steven Coutre, et al.
Leukemia & Lymphoma
|
April 26, 2013
Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia
G Doreen te Raa, Jitka Malcikova, Sarka Pospisilova, et al.
Leukemia
|
February 2, 2021
EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4<sup>+</sup> T cells in chronic lymphocytic leukemia
Philipp M Roessner, Laura Llaó Cid, Ekaterina Lupar, et al.
Blood
|
April 12, 2012
Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial
Peter Dreger, Hartmut Döhner, Fabienne McClanahan, et al.
Page
of 47